Professor of Pharmacology at the University of California at Irvine
Pro to the question "Should Marijuana Be a Medical Option?"
"Anything done in excess is bad for you. If you compare different evils, marijuana is probably one of the least and probably should still be considered as such. That is not to say that marijuana is harmless. It is a drug. All drugs - legal and illegal - can be harmful.
Everything that is potentially pharmacologically active can be potentially harmful and must be consumed with a certain degree of intelligence...No amount of scientific study will justify immoderation. There are always people who will use the latest finding to justify their weakness, but that doesn't work."
"Marijuana: The Good, the Bad, the Truth," USA Today, Mar. 16, 2000
Experts PhD's and JD's (lawyers) with significant post-doctoral involvement in medical marijuana issues; judges who have presided over medical marijuana cases. [Note: Experts definition varies by site.]
Involvement and Affiliations:
Professor of Pharmacology, University of California at Irvine
Louise Turner Arnold Chair in Neurosciences, University of California at Irvine
Former Director, Department of Pharmacology National Institute on Drug Abuse (NIDA) Training Grant, University of California at Irvine
Participant in the 2000 study of medical marijuana that appeared in the peer-reviewed scientific journal Nature
"The Molecular Logic of Endocannabinoid Signaling," Nature Reviews Neuroscience, 2003
Cowritten with Dinh, T., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, S.L., and Kathuria, S., "Brain Monoglyceride Lipase Participating in Endocannabinoid Inactivation," Proceedings of the National Academy of Sciences of the U.S.A., 2002
Cowritten with Calignano, A., Katona I., De Sarnaud F., Giuffrida, A., La Rana, G., Mackie, K., and Freund, T.F., "Bidirectional Control of Airway Responsiveness by Endogenous Cannabinoids," Nature, 2000